Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Roberto, Fiocchi"'
Autor:
Mariapina Gallo, Georgios Eleftheriou, Laura Trevisani, Mauro Gori, Filippo Taddei, Roberto Fiocchi
Publikováno v:
International journal of clinical pharmacology and therapeutics. 57(5)
Vemurafenib and cobimetinib are extremely effective in treating V600E-mutated metastatic melanoma, but their use is associated with toxic cardiac effects. Vemurafenib-induced prolonged QTc interval may be associated with ventricular fibrillation and
Autor:
Annalisa Innocente, Andrea Gianatti, E. Benazzi, Francesca Poli, Angela Nocco, Roberto Fiocchi, Nicoletta Cagni, Mario Scalamogna
Publikováno v:
Human Immunology. 72:1045-1048
The development of solid-phase assays for antibody detection has aided in the frequent detection of human leukocyte antigen (HLA) antibodies in nonalloimmunized males. Some scientists have reported that these HLA antibodies are produced to pathogens
Autor:
Roberto Fiocchi, Alessandro Rambaldi, Pieremilio Cornelli, Massimo Provenzi, Eugenia Giraldi, Valentino Conter, Giuliano Torre, Michele Colledan
Publikováno v:
Pediatric Blood & Cancer. 57:324-328
Management of aggressive, usually late-occurring, post-transplant lymphoproliferative disorders (PTLDs), a life-threatening complication after solid organ transplants, remains controversial. Four children affected by aggressive CD20+ PTLDs received a
Autor:
Elena Dall’Olio, Stefano Fagioli, Carlo Rugiu, Giampiero Girolomoni, Anna Belloni Fortina, Luigi Naldi, Roberto Fiocchi, Alberto Forni, Mauro Alaibac, Giuseppe Faggian, Eliana Gotti, Francesco Nacchia, Fabrizia Sassi, Stefano Piaserico, Luigino Boschiero, Gianpaolo Tessari
Publikováno v:
Clinical Transplantation. 24:328-333
Tessari G, Naldi L, Piaserico S, Boschiero L, Nacchia F, Forni A, Rugiu C, Faggian G, Dall’Olio E, Fortina AB, Alaibac M, Sassi F, Gotti E, Fiocchi R, Fagioli S, Girolomoni G. Incidence and clinical predictors of primary opportunistic deep cutaneou
Autor:
Giuseppe Bartoli, Giustino Di Antonio, Roberto Fiocchi, Enrico Marcantoni, Sandra Giuli, Mauro Marcolini
Publikováno v:
Synthesis. 2009:951-956
(+)-Furanomycin is an antibiotic that substitutes for L-isoleucine in bacterial protein translation. We propose here a new short synthesis of a useful intermediate, a 1,2-diprotected 2-aminopent-4-ene-1,3-diol, starting from the inexpensive natural a
Autor:
Lorenzo DʼAntiga, Carlo Foglia, Andrea Gianatti, Eugenia Giraldi, Stefania Bolognini, Michele Colledan, Valentino Conter, Massimo Provenzi, Alessandro Rambaldi, Roberto Fiocchi, R. Sebastiani
Publikováno v:
Transplantation. 100(2)
Background: Optimal management of posttransplant lymphoproliferative disease (PTLD) remains to be defined due to heterogeneity of this condition and lack of predictors of the outcome. Here we report our experience with pediatric PTLD nonresponsive to
Autor:
M Zakliczynski, Johan Vanhaecke, Heather J. Ross, Mario C. Deng, D. Hiller, Emir Deljkich, Roberto Fiocchi, J. Yee, Jayan Parameshwar, Paul Mohacsi, Pascal Leprince, Lane A. Eubank, Christoph Bara, Andreas Zuckermann, María G. Crespo-Leiro, Joerg Stypmann, Uwe Schulz, D. Hoefer
Publikováno v:
Crespo-Leiro, Maria G; Stypmann, Jörg; Schulz, Uwe; Zuckermann, Andreas; Mohacsi, Paul; Bara, Christoph; Ross, Heather; Parameshwar, Jayan; Zakliczyński, Michal; Fiocchi, Roberto; Hoefer, Daniel; Deng, Mario; Leprince, Pascal; Hiller, David; Eubank, Lane; Deljkich, Emir; Yee, James P; Vanhaecke, Johan (2015). Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients. BMC cardiovascular disorders, 15(120), p. 120. BioMed Central 10.1186/s12872-015-0106-1
RUC. Repositorio da Universidade da Coruña
instname
BMC Cardiovascular Disorders
RUC. Repositorio da Universidade da Coruña
instname
BMC Cardiovascular Disorders
Background A single non-invasive gene expression profiling (GEP) test (AlloMap®) is often used to discriminate if a heart transplant recipient is at a low risk of acute cellular rejection at time of testing. In a randomized trial, use of the test (a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61045194882353cf627eede03c27a97e
Publikováno v:
Comprehensive Therapy. 26:121-126
Risk factors for graft coronary artery disease after heart transplant are discussed in relationship to cyclosporine dosages. Patients receiving a mean cyclosporine dose higher than 4 mg/kg/day had lower incidence of graft coronary disease than patien
Publikováno v:
Transplant International. 13:S240-S244
During heart surgery, cardiac troponin I (cTn-I) measurement provides a tool to evaluate different cardioprotective techniques. To investigate myocardial protection during heart transplantation (HTx), cTn-I and creatine kinase (CK)-MB release was mea
Autor:
Cristina Manzoni, Piera Viero, Gianmaria Borleri, Teresio Motta, Bruno Gridelli, Gianpietro Dotti, Tiziano Barbui, Roberto Fiocchi, Eliana Gotti, Alessandro Rambaldi, Amando Gamba, Giuseppe Remuzzi
Publikováno v:
Transplantation. :827-833
Background. Solid organ transplant patients undergoing long-term immunosuppression have high risk of developing lymphomas. The pathogenesis of the late-occurring posttransplantation lymphoproliferative disorders (PTLD) have not yet been extensively i